“Updates on diagnostic and prognostic molecular biomarkers of CNS tumors”
Shane Eaton, Ahmad Almotairi, Adrian Levine, Cynthia Hawkins · 2026
Read “Updates on diagnostic and prognostic molecular biomarkers of CNS tumors” by Shane Eaton, Ahmad Almotairi, Adrian Levine, Cynthia Hawkins (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13602056.txt.
Description
Brain and spine tumors were once sorted by how they look under a microscope, but gene tests now share that role. Shane Eaton and co-authors review the shift in a 2026 paper on molecular markers for these tumors. The markers now help doctors name the tumor, judge its outlook, and pick treatment.
One new tool reads chemical tags on DNA to sort tumors into groups that behave alike. The review walks through major tumor families, from gliomas to meningiomas, and notes where single markers can mislead. New groups, such as repair-deficient gliomas and fusion-driven tumors, add to the map. The authors stress that care now rests on joining gene results with classic tissue review.
Catalog record
| CREATOR | Shane Eaton, Ahmad Almotairi, Adrian Levine, Cynthia Hawkins |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |